-
Mashup Score: 29
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the U.S. Food and Drug Administration (FD
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the U.S. Food and Drug Administration (FD
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the U.S. Food and Drug Administration (FD
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the U.S. Food and Drug Administration (FD
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the U.S. Food and Drug Administration (FD
Source: www.businesswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7University program puts Missouri school in world’s top 10 - 1 month(s) ago
MISSOURI (KSNF) — One university in the Show-Me State receives high marks on a global scale. Washington University in St. Louis (WUSTL) is ranked 8th in the world when it comes to their health scie…
Source: www.fourstateshomepage.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 0In vivo ablation of NFκB cascade effectors alleviates disease burden in myeloproliferative neoplasms - John T. Milliken Department of Medicine - 1 month(s) ago
Study in Blood dissecting the role of NFκB signaling effectors in MPN disease biology Stephen T. Oh, MD, PhD, Co-Chief and Associate Professor of Medicine, Division of Hematology, Department of Medicine, Washington University School of Medicine in St. Louis, and has been published in Blood. The WashU group of researchers previously identified hyperactivation of NFκB […]
Source: internalmedicine.wustl.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12
Herbicide and pesticide exposure [e.g., agent orange (AO)] is associated with an increased risk of multiple myeloma (MM) due to the contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). However, it is unclear whether TCDD/AO exposure (AO exposure hereafter) …
Source: www.ncbi.nlm.nih.govCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 4Blues announce 25th Anniversary Hockey Fights Cancer Night initiatives for Dec. 12 | St. Louis Blues - 5 month(s) ago
ST. LOUIS – The St. Louis Blues are preparing to recognize the 25th Anniversary of the National Hockey League’s fight against cancer when they host the Detroit Red Wings for Hockey Fights Cancer Night on Tuesday, Dec. 12. In conjunction with the celebration and the team’s continued efforts to raise
Source: www.nhl.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1WashU Expert: Some parasites turn hosts into 'zombies' - The Source - Washington University in St. Louis - 6 month(s) ago
While the flesh-eating undead portrayed on television are just fiction, there are clear examples of parasites that have evolved to manipulate their hosts, according to Theresa Gildner, assistant professor of biological anthropology in Arts & Sciences at Washington University in St. Louis.
Source: source.wustl.eduCategories: General Medicine News, Hem/OncsTweet
Cilta-cel Carvykti gets FDA approval for second line therapy for myeloma after proteasome inhibitor (PI), and an Imid, refractory to Len! #mmsm #celltherapy #bmtsm @RahulBanerjeeMD @Myeloma_Society @My_Cancer_Haven @DrOlaLandgren @Myeloma_Doc @Rfonsi1 https://t.co/Xnh3pgm9hV